I bought Investor's Business Daily (IBD) for Monday and used their IBD 100 list to formulate a watchlist moving forward into earnings. The stocks I have identified for either positive/negative reasons are:
*VistaPrint Ltd. (VPRT)
*Green Mountain Coffee Roasters INC (GMCR)
*Panera Bread Co.(PNRA)
*Thoratec Corp (THOR)
*Visa (V)
*Granite Construction INC (GVA)
*Edwards Lifesciences Corp (EW)
*American Italian Pasta Co.(AIPC)
Trials and tribulations of my stock trading and investing experiences. Lessons learned, both good and bad...that will hopefully benefit others.
Custom Search
Showing posts with label ibd. Show all posts
Showing posts with label ibd. Show all posts
Sunday, April 05, 2009
Tuesday, April 29, 2008
Don't Buck the Trend
I'm a sucker for reading material and author's who are willng to share their investment styles and what has worked and not worked for them in the past. Right now I'm reading "The New Day Trader Advantage," by Jon D. Markman. In his book, he reminds us investors/traders about trend and market momentum: (1) A stock's sector can account for up to 50 to 60 percent of its movement, up to 20 percent from market cap and valuation group, 10 percent from its region, and the remaining falling to the discretion of the investee.
With all that in mind, I typically research the Monday edition of Investor's Business Daily for its 197 Industry Sub-Group Rankings, which is based on 6-month price performance. The current groups making up a majority of the top 20 are: Oil & Gas, Machinery, Metals, and Chemicals. With all this mind my focus has been in the Chemicals and Metals arena, specifically RIO, AGU, and SLT. I also like the fact that each of the afforementioned stocks are foreign based: RIO (Brazil), AGU (Canada), and SLT (India) Right now, I only own SLT, but waiting for some pullback on RIO and AGU before getting back in. Just a few of my thoughts. Anyone else willing to share what works for them? HAGO Justin
With all that in mind, I typically research the Monday edition of Investor's Business Daily for its 197 Industry Sub-Group Rankings, which is based on 6-month price performance. The current groups making up a majority of the top 20 are: Oil & Gas, Machinery, Metals, and Chemicals. With all this mind my focus has been in the Chemicals and Metals arena, specifically RIO, AGU, and SLT. I also like the fact that each of the afforementioned stocks are foreign based: RIO (Brazil), AGU (Canada), and SLT (India) Right now, I only own SLT, but waiting for some pullback on RIO and AGU before getting back in. Just a few of my thoughts. Anyone else willing to share what works for them? HAGO Justin
Labels:
agu,
brazil,
canada,
ibd,
india,
jon markam,
market cap,
rio,
slt,
valuation
Sunday, January 20, 2008
IBD Healthcare Update
Went over the latest IBD and it looks like the healthcare has advanced according to IBD, however I am not willing to take it at strictly face value which I will explain. This week there is 11 healthcare-related industries within the top 25 a whopping 44% representation and they are:
#2 Medical/Dental-Services
#3 Medical-Ethical Drugs
#5 Medical-Genetics
#6 Medical-Systems/Equipment
#12 Medical-Health Maintenance Organizations
#13 Medical-Products
#15 Medical-Wholesale Drug/Supply
#16 Medical-Drug/Diversified
#17 Medical-Outpatient/Home Care
#18 Medical-Biomed/Biotech
#24 Medical-Generic/Drugs
This sounds and looks great on the surface, however here is my concern. I sometimes use the IBD 100 to help focus on some momentum stocks and have a set of criteria I follow with regards to overall stock rank and group ranking. Normally, I will have my steady performers who are always on the list in one form or another i.e. POT, ISRG, VIP etc...However this week there was a tremendous amount of new companies into my numbers on the order of +35%, which is not normal. I find during volatile times some companies make a big move one week, so they find themselves into my numbers, but drop out shortly thereafter.
So you may ask...How does this all tie into healthcare? Well, 8 of the 20 new entries are related to the healthcare industry, so I am a bit hesitant and have a gut feeling that there may be more "pain" to follow. Here are those new entries
1. Yamana Gold INC (AUY)
2. Blackrock (BLK)
3. American Public Education INC (APEI)
4. Omnicell (OMCL) (I do own shares of this company)
5. Flir Systems INC (FLIR)
6. Amedisys (AMED)
7. Energen (EGN)
8. Strayer Education (STRA)
9. Invitrogen (IVGN)
10. Icon Plc ADS (ICLR)
11. Covance (CVD)
12. Mechel Oao ADS (MTL)
13. Stericycle (SRCL)
14. Genzyme Corp (GENZ)
15. Berkshire Hathaway A (BRKA)
16. Kendle Intl (KNDL)
17. Apollo Group A (APOL)
18. Cellcom Israel Ltd (CEL)
19. Axsys Tech (AXYS)
20. Continental Res INC (CLR)
#2 Medical/Dental-Services
#3 Medical-Ethical Drugs
#5 Medical-Genetics
#6 Medical-Systems/Equipment
#12 Medical-Health Maintenance Organizations
#13 Medical-Products
#15 Medical-Wholesale Drug/Supply
#16 Medical-Drug/Diversified
#17 Medical-Outpatient/Home Care
#18 Medical-Biomed/Biotech
#24 Medical-Generic/Drugs
This sounds and looks great on the surface, however here is my concern. I sometimes use the IBD 100 to help focus on some momentum stocks and have a set of criteria I follow with regards to overall stock rank and group ranking. Normally, I will have my steady performers who are always on the list in one form or another i.e. POT, ISRG, VIP etc...However this week there was a tremendous amount of new companies into my numbers on the order of +35%, which is not normal. I find during volatile times some companies make a big move one week, so they find themselves into my numbers, but drop out shortly thereafter.
So you may ask...How does this all tie into healthcare? Well, 8 of the 20 new entries are related to the healthcare industry, so I am a bit hesitant and have a gut feeling that there may be more "pain" to follow. Here are those new entries
1. Yamana Gold INC (AUY)
2. Blackrock (BLK)
3. American Public Education INC (APEI)
4. Omnicell (OMCL) (I do own shares of this company)
5. Flir Systems INC (FLIR)
6. Amedisys (AMED)
7. Energen (EGN)
8. Strayer Education (STRA)
9. Invitrogen (IVGN)
10. Icon Plc ADS (ICLR)
11. Covance (CVD)
12. Mechel Oao ADS (MTL)
13. Stericycle (SRCL)
14. Genzyme Corp (GENZ)
15. Berkshire Hathaway A (BRKA)
16. Kendle Intl (KNDL)
17. Apollo Group A (APOL)
18. Cellcom Israel Ltd (CEL)
19. Axsys Tech (AXYS)
20. Continental Res INC (CLR)
Labels:
biomedical,
drug,
generic,
healthcare,
ibd,
IBD 100,
medical,
stocks
Sunday, January 13, 2008
Healthcare According to IBD

Here are the latest statistics per the latest Investor's Business Daily. I have compiled the numbers for easier reading. IBD breaks down the marketplace into 197 various industry groups. The rankings are compiled based on price performance of all stocks in the industry in the latest 6 months and according to IBD studies show most top-performing stocks are found in the top quartile of groups and that group action determines at least half of a stock's performance.Out of the top 30 industry groups, the healthcare industry comprises 33% of this list. The 10 industries making the list are:
#4. Medical-System/Equipment
#6. Medical/Dental Services
#7. Medical Genetics
#8. Medical-Ethical Drugs
#12. Medical-Health Maintenance Organization
#18. Medical-Products
#19. Medical-Wholesale Drug Supply
#23. Medical-Outpaitent/Home Care
#24. Medical-Drug/Diversified
#25. Medical-Biomedical/Biotechnology
In addition, the healthcare sector is up 1.87% YTD, while 18 individual stocks raked up new highs and no new lows, which I find a bit impressive with the market we have been having.
Labels:
biomedical,
biotechnology,
drug,
genetics,
healthcare,
hmo,
housing market,
ibd,
medical
Tuesday, January 08, 2008
VIVO Las Vegas!

Of course that title should be Viva Las Vegas, however I'm here to briefly talk about Meridian Bioscience (VIVO). This company is in the Healthcare sector specifically the diagnostic substances industry. I have been watching this company work its way in and out of the IBD 100 and was recently ranked towards the bottom at #98. What peaks my interest is the fact that this sector remains positive, while other sectors are taking drubbings. This stock is up over 8% since last Friday on larger than average volume and it looks like it may be beginning to build a base according to the charts. I could envision how someone could possibly play this stock for a short-term pop or longer term investment depending on style and risk-level. The market has been acting crazy lately, so this is NOT a recommendation to buy/sell this stock just something that has sparked my interest, so do please do your own due diligence.
Labels:
bioscience,
healthcare,
ibd,
meridian,
stock,
vivo,
volume
Subscribe to:
Posts (Atom)